Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
QBAK
3726
DELISTED
Qualstar Corp
QBAK
| $133K | ﹤0.01% |
25,985
| – | – |
2015 Q3
7 quarters
|
|
3727
iBio
IBIO
$50.3M
| $132K | ﹤0.01% |
69
| – | – |
2013 Q2
16 quarters
|
|
3728
DELISTED
Golden Minerals Company
AUMN
| $132K | ﹤0.01% |
9,446
| – | – |
2013 Q2
16 quarters
|
|
|
DVCR
3729
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $129K | ﹤0.01% |
13,755
| – | – |
2013 Q2
16 quarters
|
|
|
ADAP
3730
DELISTED
Adaptimmune Therapeutics
ADAP
| $128K | ﹤0.01% |
28,605
+11,764
| +70% | +$61.5K |
2016 Q2
4 quarters
|
|
3731
Tuniu
TOUR
$53.9M
| $128K | ﹤0.01% |
1,605
-433
| -21% | -$35.6K |
2016 Q1
5 quarters
|
|
3732
Aegon
AEG
$12.2B
| $127K | ﹤0.01% |
31,614
+14,909
| +89% | +$58.4K |
2016 Q4
2 quarters
|
|
|
AMPE
3733
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $127K | ﹤0.01% |
813
-231
| -22% | -$46.7K |
2013 Q2
16 quarters
|
|
3734
DELISTED
DZS Inc. Common Stock
DZSI
| $127K | ﹤0.01% |
21,270
-2,035
| -9% | -$12.1K |
2013 Q2
16 quarters
|
|
|
SUMR
3735
DELISTED
Summer Infant, Inc.
SUMR
| $127K | ﹤0.01% |
7,975
-304
| -4% | -$4.97K |
2013 Q2
16 quarters
|
|
3736
Cemtrex
CETX
$3.08M
| – | – |
0
| – | – |
2015 Q3
7 quarters
|
|
3737
CorMedix
CRMD
$581M
| $126K | ﹤0.01% |
59,002
+22,598
| +62% | +$77.3K |
2014 Q1
13 quarters
|
|
3738
Innodata
INOD
$1.95B
| $126K | ﹤0.01% |
72,296
-8,094
| -10% | -$14.5K |
2013 Q2
16 quarters
|
|
|
PBBI
3739
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $126K | ﹤0.01% |
11,925
| – | – |
2017 Q1
1 quarter
|
|
3740
Ideal Power
IPWR
$52.8M
| $124K | ﹤0.01% |
5,933
| – | – |
2014 Q1
13 quarters
|
|
3741
Friedman Industries
FRD
$298M
| $123K | ﹤0.01% |
21,701
| – | – |
2013 Q2
16 quarters
|
|
3742
Research Frontiers
REFR
$22.3M
| $123K | ﹤0.01% |
95,951
-3,814
| -4% | -$4.79K |
2013 Q2
16 quarters
|
|
3743
eGain
EGAN
$146M
| $122K | ﹤0.01% |
72,309
-5,742
| -7% | -$8.95K |
2013 Q2
16 quarters
|
|
|
SUNW
3744
DELISTED
Sunworks, Inc.
SUNW
| $122K | ﹤0.01% |
9,980
| – | – |
2015 Q2
8 quarters
|
|
3745
Compugen
CGEN
$197M
| $121K | ﹤0.01% |
32,064
+2,086
| +7% | +$8.68K |
2014 Q4
10 quarters
|
|
3746
Star Equity Holdings
STRR
$36.9M
| $121K | ﹤0.01% |
9,090
-627
| -6% | -$8.58K |
2013 Q2
16 quarters
|
|
3747
Great Elm Group
GEG
$64.2M
| $120K | ﹤0.01% |
35,396
| – | – |
2013 Q2
16 quarters
|
|
3748
Kamada
KMDA
$452M
| $119K | ﹤0.01% |
19,905
+3,364
| +20% | +$23.9K |
2015 Q1
9 quarters
|
|
|
AMRS
3749
DELISTED
Amyris Inc.
AMRS
| $119K | ﹤0.01% |
37,574
-1,628
| -4% | -$8.79K |
2013 Q2
16 quarters
|
|
3750
Presurance Holdings
PRHI
$30.5M
| $118K | ﹤0.01% |
2,367
| – | – |
2016 Q3
3 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.